Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

/PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines…Read More